国产雷帕霉素药物洗脱支架治疗冠心病前降支弥漫性长病变的疗效分析
张利彬;甘舜进;郭金城;张学坤;张海滨;高国旺;
摘要(Abstract)：
目的评价国产雷帕霉素药物洗脱支架在冠心病前降支弥漫性长病变治疗中的安全性和有效性。方法选择我院2004年10月—2007年10月经冠脉造影证实的冠心病前降支弥漫性长病变患者174例,其中接受国产雷帕霉素药物洗脱支架组(简称Firebird组)98例,接受进口雷帕霉素药物洗脱支架组(简称Cypher组)76例。对比两组患者一般临床情况、手术成功率和术后随访主要心脏事件(包括再发心绞痛、再发心肌梗死、再次血运重建、死亡等)发生率。结果两组患者支架手术成功率相似,随访12个月,两组患者均无急性与亚急性支架内血栓形成、无再发心肌梗死。两组再发心绞痛、再次血运重建比较差异无统计学意义。结论国产雷帕霉素药物洗脱支架应用于冠心病前降支弥漫性长病变安全有效,能改善患者的近期和远期预后。
关键词(KeyWords)： 雷帕霉素;冠状动脉;血管成形术
基金项目(Foundation):
作者(Author): 张利彬;甘舜进;郭金城;张学坤;张海滨;高国旺;
Email:
DOI:
参考文献(References)：
- 1 Moes JW,Leon MB,Popma JJ,et al.Sirolimus-eluting stentgs ver-sus standard stents in patients with stenosis in a native coronary artery[J].N Engl J Med,2003,349:1315-1325.
- 2 Bauters C,Hubert E,Part A,et al.Predictors of restenosis after cor-nery stent implatation[J].J Am Coll Cardiol,1998,31:1291-1293.
- 3 Hausleiter J,sebastion M,Li AN,et al,A porcine coronary stentmodel of increased neotntima formation in the left anterior descendingcornary arter[J].J Cardiol,2002,91:614-616.
- 4 Schofer J,Schluter M,Gershlick AH,et al.Sirdimus-eluting fortreatment of patients with long atherosclerotic lesions in small coronaryarteries:double-blind randomized controlledtrial(E-SIRUS)[J].Lancet,2003,362:1093-1099.
- 5 Schampaert E,Cohen EA,Schluter M,et al,The Canadian study ofthe sirolimus-eluting stent in the treatment of patients with long de novolesions mallnative coronary arteries(C-Smros)[J].J AM Coll Car-diol,2004,43:1110-1115.
- 6 Sousa JE,Costa MA,Abizaid A,et al.four-year angiographic andintravascular ultrasound fllow-up of patients treated with sirolimus-e-luting stents[J].Circulation,2005,111:2326-2329.
- 7 Shen W,Zhang R,Shen Y,et al,optimal timing of coronary stentingin unstable agina patients[J].Chin Med J,2001,114(1):59-61.
- 8王伟民,吴淳,韩雅君,等.雷帕霉素药物洗脱支架CYPHER治疗前降支长病变的临床研究[J].中国介入心脏病学杂志,2003,10:242-243.
- 9徐义先,刘宇,杨振坤,等.国产药物洗脱支架治疗冠心病病变的近期疗效[J].中华心血管杂志,2005,8:759-761.
文章评论(Comment)：
|
||||||||||||||||||
|
||||||||||||||||||